WCG IPO Presentation Deck

Evidence of Our Impact - WCG's Significant Participation in FDA Approved Drugs FY 2020 New Therapeutic Agents Approved by FDA Breakthrough Therapies Oncology & Hematology Therapies Neurology & Psychiatry Therapies Total WCG Approved Involvement 53 46 18 17 6 16 17 6 % of Total 87% 89% 100% 100% >2WCG Business Lines 30 13 16 2 wcg % of Total in Q1 2021 87% DN L 100% 100% 100%

View entire presentation